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The roots of Glycyrrhiza glabra, Withania somnifera, Asparagus racemosus, and Chlorophytum borivilianum and seeds of Sesamum
indicum are ayurvedic medicinal plants used in India to treat several ailments. Our previous studies indicated that these plants
possesshypolipidemic and antioxidant potential. The present studywas aimed at investigating the composite eﬀects ofthese plants
on hypercholesterolemic rats. Three diﬀerent combinations (5gm%, given for four weeks) used in this study eﬀectively reduced
plasma and hepatic lipid proﬁles and increased fecal excretion of cholesterol, neutral sterol, and bile acid along with increasing the
hepatic HMG-CoA reductase activity and bile acid content in hypercholesterolemic rats. Further, all three combinations also
improved the hepatic antioxidant status (catalase, SOD, and ascorbic acid levels) and plasma total antioxidant capacity with
reduced hepatic lipid peroxidation. Overall, combination I had the maximum eﬀect on hypercholesterolemic rats followed by
combinations II and III due to varying concentrations of the diﬀerent classes of phytocomponents.
1.Introduction
Hypercholesterolemia is one of the major risk factors that
precipitatecoronaryheartdisease(CHD)andatherosclerosis
[1].Besidesmedication,compositionofthedietalsoplaysan
important role in the management of lipid and lipoprotein
concentrations in blood. Plant-based therapies are recog-
nized for their therapeutic applications as they either have
minimal or no side eﬀects [1, 2]. Over the past 20 years or so,
interest in traditional medicines has increased considerably
inmanypartsof theworld. Traditional medicines alloverthe
worldarebeingreevaluatedbyextensiveresearchondiﬀerent
plant species with regard to their therapeutic principles and
potential. Despite the progress in conventional chemistry
and pharmacology in producing eﬀective drugs, the plant
kingdom might yet provide useful sources of new medicines.
Plants produce an amazing variety of metabolites such
as isoﬂavones, phytosterols, saponins, ﬁbers, polyphenols,
ﬂavonoids, and ascorbic, and these have aroused much inter-
est for their role in lipid and antioxidant metabolism [3–7].
Severalherbalcombinationshavebeentestedexperimen-
tally for their potential in ameliorating various ailments, for
example, diabetes, allergic rhinitis, atherosclerosis, rheuma-
toidarthritis,andantimicrobialactivity[7–12].Forinstance,
an experimental combination (of roots of ashwagandha,
rhizomes of ginger, and young mulberry leaves) treatment
given to NIDDM human subjects revealed a signiﬁcant
reduction in blood glucose, total cholesterol, triglycerides,
LDL cholesterol and VLDL cholesterol [13].
A number of polyherbal formulations to treat various
disorders are also being marketed by several reputed
ayurvedic drug manufacturers in India which include among
others Chyawanprash, Active Blood Puriﬁer (44 and 7 herbs,
resp.; Dabur India Ltd.), D-400, Liv 52, OST-6, Cystone (32,
7, 5, and 7 herbs, resp.; Himalaya Drug Co.), Livergen (6
herbs;StandardPharmaceuticals),Livokin(17herbs;Herbo-
Med),Stimuliv(4herbs;Franco-IndianPharmaceuticalsPvt.
Ltd.), Tefroliv (9 herbs; TTK Pharma Pvt. Ltd.), Panka-
jakasthuri (14 herbs; Herbals India Pvt. Ltd.), and Dihar (8
herbs; Rajsha Pharmaceuticals).2 Oxidative Medicine and Cellular Longevity
The present investigation is aimed at ﬁnding an eﬀective
combination of diﬀerent proportions of certain medicinal
plants which could supplement as a therapeutic agent for
hyperlipidaemia. The plants used in the present investi-
gation, that is, Glycyrrhiza glabra (F. Fabaceae), Withania
somnifera (F. Solanaceae), Asparagus racemosus (F. Liliaceae),
Chlorophytum borivilianum (F. Liliaceae), and Sesamum
indicum(F.Pedaliaceae),haveethnobotanicalhistoryandare
widely used in Ayurvedic System of Medicine in India for
various ailments. Our previous work on G. glabra, C. boriv-
ilianum, W. somnifera, S. indicum,a n dA. racemosus showed
dose-dependent (5 and 10gm% of roots/seed powder) bene-
ﬁcial eﬀects on hypercholesterolemic rats [14–18]. We found
that G. glabra was the most potent of the plants studied
with reference to hypolipidaemic/hypocholesterolemic and
antioxidant eﬀects followed by W. somnifera, A. racemosus,
C. borivilianum,a n dS. indicum. In this study, we have
investigated the eﬀect of diﬀerent combinations of these
plants on lipid proﬁles, fecal-cholesterol, neutral sterol, and
bile acid excretion patterns and the consequent eﬀects on
hepatic cholesterol and bile acid production in hyperc-
holesterolemic rats. An attempt was also made to study
the status of hepatic lipid peroxidation, the proﬁles of
antioxidants-catalase, superoxide dismutase, and ascorbic
acid as well as ferric reducing ability of the plasma (FRAP)
in hypercholesterolemic rats.
2. Results
2.1. Phytoconstituents and FRAP Value in Diﬀerent Com-
binations. The quantitative phytochemical analysis of all
three combinations (C-I, C-II, and C-III) indicated that
these combinations contained ﬁber, phytosterols, saponin,
polyphenol, ﬂavonoids, and ascorbic acid. The FRAP values
as total antioxidant concentrations in combinations I, II, and
III indicated the highest value for C-I followed by C-II and
C-III (Table 2).
2.2. Body Weight, Food Intake, and Liver Weight. There were
no signiﬁcant diﬀerences in food intake or body weights in
any group (NC, HC, C-I, C-II, and C-III). However, liver
weight decreased signiﬁcantly (P < 0.002) in C-I (15%), C-
II (14%), and C-III (12%) groups compared to HC animals
(data not presented).
2.3. Plasma and Hepatic Lipid Proﬁles. The plasma lipid
proﬁles signiﬁcantly decreased (P < 0.002) with all three
combinations. All three groups (C-I, C-II, and C-III) regis-
tered signiﬁcant decline in plasma TL (C-I: 30%; C-II: 32%;
C-III: 20%), TC (40%; 43%; 29%), TG (28%; 15%; 14%),
and LDL (53%; 57%; 37%) levels, and an increase in
HDL- C (35%; 37%; 21%, P < 0.002) was noted in these
groups as compared to HC group (Figure 1). Very-low-
density lipoprotein (VLDL) levels in the test groups (C-I:
7.8±0.2; C-II: 9.2±0.2; C-III: 9.3±0.2mg/dL, P <
0.002) were signiﬁcantly lower than in HC group (10.8±
0.2mg/dL). Thus, the combination diets reduced the
VLDL concentrations by 28%, 15%, and 14%, respectively.
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Figure 1: Eﬀect of feeding diﬀerent combinations on plasma lipid
proﬁles (mg/dL). NC: normal controls; HC: hypercholesteremic
animals; C-I: hypercholesterolemic animals administered with
5gm% combination-I; C-II: hypercholesteremic animals admin-
istered with 5gm% combination-II; C-III: hypercholesteremic
animalsadministeredwith5gm%combination-III.Values:mean ±
SEMand(n=6);FRAP-value=(μmol/Liter).Signiﬁcantdiﬀerences
(P < 0.002) among the groups are denoted by a, b, c, and d.
Similarly, the atherogenic index (AI) was also reduced in
the combination-diet-treated groups (C-I: 3.3±0.1; C-II:
3.1±0.1; C-III: 4.4±0.1, P < 0.002) as compared to HC
group (7.6±0.3). The hepatic lipid proﬁles too signiﬁcantly
declined (P < 0.002) in the test groups: TL (by 28%, 34%,
and20%inC-I,C-II,andC-III,resp.)andTC(by31%,35%,
and 20% in C-I, C-II, and C-III, resp.) but not signiﬁcantly
TG (by 17%, 9%, and 8% in C-I, C-II, and C-III resp., P <
0.002) as compared to HC group (Table 3).
2.4. Hepatic HMG-CoA Reductase and Bile Acids Levels.
Administration of diﬀerent combinations to hypercholes-
terolemic rats resulted in a signiﬁcant increase in (P < 0.002)
hepatic HMG-CoA reductase activity (C-I, C-II, and C-III
groups: 16%, 19%, and 13%, resp.) as compared to HC
group. Hepatic bile acid content also increased (P < 0.002,
27%; 33%; 16%) in these groups as compared to those of
hypercholesterolemic control group (Table 3).
2.5. Fecal Cholesterol, Neutral Sterols, and Bile Acid Content.
There were increments (P < 0.002) in fecal cholesterol (15%;
19%; 11%), neutral sterol (19%; 23%; 12%) and bile acid
(29%; 34%; 18%) excretion in C-I, C-II, and C-III groups
as compared to HC group (Table 4).
2.6. Hepatic Lipid Peroxidation and Antioxidant Proﬁles. The
hepatic lipid peroxidation decreased signiﬁcantly (P < 0.002)
in all three groups (C-I: 33%, C-II: 26%, and C-III: 17%)
when compared to that of HC group. Both catalase (P <
0.002, C-I: 36%, C-II: 32%, and C-III: 14%) and SOD (P <
0.002, C-I: 27%, C-II: 20%, and C-III: 19%) activities also
increased in these groups signiﬁcantly compared to those
in HC group (Figure 2). The C-I, C-II, and C-III group
rats registered had increased hepatic ascorbic acid contentOxidative Medicine and Cellular Longevity 3
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Figure 2: Eﬀect of feeding diﬀerent combinations on hepatic
concentrations of lipid peroxidation (LPO), activities of catalase,
and superoxide dismutase (SOD). Values: mean ± SEM and (n = 6).
Signiﬁcantdiﬀerences(P <0.002)amongthegroupsaredenotedby
a, b, c, and d.
(132.7 ± 3.8; 114.3 ± 3.1; 110.3 ± 3.2μg/g, P < 0.002) as
compared to the hypercholesterolemic (95.5 ± 2.8μg/g) rats.
FRAP values increased in all groups that is, C-I, CII, and C-
III (P < 0.002, 35%; 29%; 21%, resp.), as compared to HC
group (Figure 1).
3. Discussion
Thepresentinvestigationdemonstratesthattheplantcombi-
nationsusedinthisstudyareeﬀectiveinloweringcholesterol
levels in hypercholesterolemic rats. Plant metabolites, the
sterols, soybean proteins, and ﬁbers are reported to reduce
the risk of CHD through their cholesterol lowering prop-
erties, independently and also in combination [8]. In this
study, the observed cholesterol-lowering eﬀects of diﬀerent
plant combinations administered to hypercholesterolemic
rats could be related to an increased excretion of cholesterol,
neutral sterols, and bile acid. The phytochemical analysis of
thecombinations(C-I,C-II,andC-III)revealedthepresence
of ﬁbers, saponins, phytosterols, polyphenols, ﬂavonoids,
and ascorbic acid among which phytosterols, ﬁbers as well
as saponins could be important in cholesterol elimination
in hypercholesterolemic rats administered with diﬀerent
combinations. These components have received consider-
able attention for their plasma cholesterol-lowering eﬀects
[3, 19–21]. It is known that phytosterols have a greater
aﬃnity for micelles than cholesterol because of their greater
hydrophobicity. Therefore, they can easily displace intestinal
cholesterol from the micelles, reducing intestinal cholesterol
absorption, and consequently reduce hepatic and plasma
cholesterol concentrations [21, 22]. Dietary ﬁbers appear to
interfere with cholesterol absorption and its enterohepatic
bile circulation resulting in depletion of hepatic cholesterol
pools and alteration in lipoprotein metabolism. Besides, the
cholesterol lowering eﬀect of ﬁbers is considered primarily
due to an increased excretion of cholesterol and bile
acids [19, 23]. Saponins are also capable of precipitating
cholesterol from micelles and interfering with enterohepatic
circulation of bile acids making it unavailable for intestinal
absorption and hence reduce plasma cholesterol levels [20,
24]. It is noteworthy that the excretion of cholesterol, neutral
sterol, and bile acid was signiﬁcantly higher with administra-
tion of diﬀerent plant combinations when compared to that
of hypercholesterolemic rats. These losses of fecal cholesterol
and bile acid could have depleted hepatic cholesterol levels,
and, as a consequence, a compensatory increase in hepatic
cholesterogenesis and bile acid synthesis was noted with
demonstrably higher hepatic HMG-CoA reductase activity
a n db i l ea c i dp r o d u c t i o ni nd i ﬀerent combination groups
as compared to those of hypercholesterolemic control rats.
A signiﬁcant decline in plasma LDL-cholesterol along with
increased bile acid production in diﬀerent combination
groups could also be due to the ﬁber and saponin content
of combinations as both ﬁbers and saponins are reported
to lower plasma LDL-cholesterol levels via interruption of
cholesterol and bile acid absorption and increased LDL-
receptor activity; the LDL-cholesterol could then be subse-
quently catabolized to bile acid [23, 25].
Rats fed diﬀerent combinations had lower hepatic and
plasma TG concentrations than rats fed cholesterol alone.
The TG depletion may be related to the ability of ﬁber
to inhibit absorption of lipids from the intestinal lumen
[23]. Moreover, saponins are reported to inhibit pancreatic
lipase activity and reduce the TG concentrations [26] leading
to subsequent reduction in the VLDL-C concentration in
plasma [22]. Presently all three experimental groups (C-I,
C-II and C-III) showed a simultaneous decline in plasma
TG and VLDL-C levels that could be correlated with the
ﬁber and saponin content of the experimental diets. Several
studies documented that low levels of HDL-cholesterol are
indicative of high risk for CHD and an increase in HDL-
C level is considered beneﬁcial [1]. Epidemiological studies
have also shown that high HDL-cholesterol levels could
potentially contribute to antiatherogenecity, inhibit LDL-
oxidation and protect endothelial cells from the cytotoxic
eﬀects of oxidized LDL [27]. Presently noted high levels
of plasma HDL-cholesterol in hypercholesterolemic animals
administered with diﬀerent combinations as compared to
HC animals indicate the physiological role played by these
combinations in elevating HDL-cholesterol levels. While
dietary saponins and ﬁbers are not known to elevate HDL-
c h o l e s t e r o ll e v e l s[ 20, 23], ascorbate and ﬂavonoids are
reported to increase the HDL-cholesterol concentrations
[28]. As the combinations contained both ascorbic acid and
ﬂavonoids, the increased HDL-cholesterol levels in hyperc-
holesterolemic animals administered with combination diets
could be attributed to these plant metabolites.
Recent studies have demonstrated a direct relationship
between hypercholesterolemia and CHD [1]. The dietary
cholesterol during its metabolism is delivered to the hepatic
cells where substantial amounts of reactive oxygen species
are generated [29]. This process is believed to generate
highly toxic products, including lipid peroxides as aldehydes,
epoxides and carbonyls, and cause rapid consumption of
antioxidants such as vitamin E or vitamin C [29]. Further,
high cholesterol diet increases serum LDL levels, and, due4 Oxidative Medicine and Cellular Longevity
to oxidative stress, the LDL is oxidized increasingly thereby
facilitating atherosclerotic plaque formation [30]. Many
studies have shown that dietary polyphenols, ﬂavonoids,
carotenoids, vitamin C, and lignans can eﬀectively scavenge
free radicals, reduce the levels of lipid peroxidation and oxi-
dationofLDLand,preventtheprogressofatherosclerosis[3,
28, 30–32]. The polyphenols with their antioxidant activity,
chieﬂy due to their redox properties, act as reducing agents,
hydrogen donors, and singlet oxygen quenchers with a metal
chelating potential [3, 32]. The polyphenols and ﬂavonoids
are reported to scavenge free radicals, including hydroxyl
and superoxide anions, stimulate SOD and catalase gene
expression, reduce the malondialdehyde concentrations, and
improve lipid proﬁles in experimental animals [10, 32, 33].
Ascorbic acid is a major chain-breaking antioxidant against
free radicals and conjugates with cytotoxic, genotoxic, and
lipid peroxidation products to eliminate them [34]. The root
extract of G. glabra has antioxidant activity reportedly due to
the presence of a variety of phenolic compounds including
ﬂavonoids, isoﬂavonoids, chalcones, and bibenzyls [35].
The antioxidant and antiperoxidative properties of sesame
seed are related to lignans, such as sesamol, sesamolinol,
pinoresinol,andsesaminol[31].ThesitoindosidesVII-Xand
Withaferin A (Glycowithanolides) of W. somnifera have been
implicated in increasing the antioxidant activity in rat brain
and stimulated catalase and SOD activities [36]. In the
present study, high cholesterol (HC) fed rats showed a
remarkable decline in antioxidant status and concurrently
increased lipid peroxidation as compared to the normal
control (NC) rats. However, all three combinations treated
hypercholesterolemic rats indicate considerable decrease in
lipid peroxidation and improvement in the antioxidant
status. Further, the aqueous extract and plasma FRAP-values
as well as hepatic catalase, SOD and ascorbic acid levels
of C-I were highest compared to C-II and C-III groups.
The malondialdehyde level in C-I group also showed a
signiﬁcant decline as compared to C-II and C-III groups.
The phytochemical analyses of combinations have indicated
the presence of polyphenols, ﬂavonoids, and ascorbic acid.
Consequently, these elevated levels of hepatic antioxidants in
combinations-treated rats might be due to the presence of
polyphenols and ﬂavonoids in the experimental diet. In this
context, our recent in vitro studies on aqueous and ethanolic
extracts of G. glabra, A. racemosus, C. borivilianum, and S.
indicum demonstrated that these plants possess considerable
free radical scavenging potency against superoxide, nitric
oxide,andhydroxylradicalsduetophenoliccontentofplants
[37–40]. In addition, these plants markedly suppressed the
metal-catalyzed lipid peroxidation in hepatic mitochondrial
f r a c t i o n si s o l a t e df r o mr a t sa sw e l la sf a v o r a b l ya ﬀected
atherosclerosis risk status by reducing human serum and
LDLoxidationcausedbycopperion[37–40].Takentogether,
presently observed high antioxidant status in combinations-
treated hypercholesterolemic rats may be due to free radical
scavenging action exerted by combinations diet. Addition-
ally, the combinations could be a potent source for ascorbic
acid as it suppressed the propagation of lipid peroxidation
andreducedthelevelsofmalondialdehyde.Unlikeourearlier
reports on these individual plants [14–18], the combinations
Table 1: Combinations of diﬀerent plants (5gm%) used.
Plants C-I (gm) C-II (gm) C-III (gm)
Glycyrrhiza glabra 1.5 0.625 1
Withania somnifera 1.25 0.75 1
Asparagus racemosus 0.875 0.875 1
Chlorophytum borivilianum 0.75 1.25 1
Sesamum indicum 0.625 1.5 1
used in the present investigation (C-I, C-II, and C-III) are
with much lower levels of additions of individual plants
(rangingbetween0.625and1.5gmasagainst5and10gm%)
in the diet (Table 1). Yet these combinations signiﬁcantly
reducedthe lipid proﬁlesandimproved the body antioxidant
capacity of hypercholesterolemic rats. Thus, the herbal
combinations-C-I, C-II, and C-III, exhibited diﬀerential
hypocholesterolemic and antioxidant activities when fed to
hypercholesterolemic rats. This could be due to varying con-
centrations of diﬀerent classes of phytocomponents in the
combinations such as ﬁber, phytosterols, saponins, polyphe-
nols, ﬂavonoids and vitamin C (Table 2). In conclusion,
although all the three tested combinations of plants were
eﬀective as hypocholesterolemic and antioxidant agents, C-
I appeared to be more potent in reducing body lipid proﬁles
and lipid peroxidation and improving the antioxidant status
of hypercholesterolemic rats.
4.MaterialsandMethods
4.1. Preparation of Plant Combinations and Phytochemical
Analysis. The roots of Glycyrrhiza glabra (GG) and seeds of
Sesamum indicum (SI) were purchased from the local mer-
chandise and roots of Withania somnifera (WS), Asparagus
racemosus (AR) and Chlorophytum borivilianum (CB) were
collected from University Botanical Gardens and authenti-
cated by our faculty Taxonomist Dr. A. S. Reddy. Roots and
seeds were air-dried completely, ground to powder, and used
for preparation of diﬀerent combinations (i.e., combinations
I, II, and III). All combinations were prepared using a 5gm%
mixture of roots/seed powder of the plants (Table 1).
Phytoconstituents of C-I, C-II, and C-III were quantiﬁed
by standard methods. The total ﬁber, polyphenol, and
ﬂavonoid were estimated according to Thimmaiah [41].
Phytosterol and saponin contents of the combinations were
estimated using ferric chloride-sulphuric acid and vanillin-
sulphuric acid methods, respectively, with β-sitosterol and
saponin as standards [42, 43]. The total ascorbic acid
content was estimated using 2,4-dinitrophenyl hydrazine
reagent [44]. The ferric-reducing ability of combinations
(FRAP)weremeasuredastheconcentrationsoftotalantioxi-
dantsusingtheTPTZ(2,4,6-tripyridyl-s-triazine)HCl-FeCl3
reagent at 593nm. Calibration curve of ferrous sulfate was
used [45].
4.2. Animals. Male albino rats (Charles Foster, bred in the
Department’s Animals House, weighing 150–200gm) were
housed individually with ad libitum access to water and fedOxidative Medicine and Cellular Longevity 5
Table 2: Phytoconstituents of feed combinations (triplicate values: mean ± SD).
Phytoconstituents mg/gm dry tissue Combination I Combination II Combination III
Fiber 132.66±1.15 (13.266%) 125.66±1.15 (12.566%) 102±1.73 (10.2%)
Phytosterols 13.13±0.34 (1.313%) 16.31±0.65 (1.631%) 10.57±0.67 (1.057%)
Saponins 52.60±1.18 (5.260%) 59.10±1.23 (5.910%) 42.96±1.05 (4.296%)
Polyphenols 16.17±1.15 (1.617%) 12.65±0.87 (1.265%) 10.37±0.62 (1.037%)
Flavonoids 4.39±0.42 (0.439%) 3.07±0.27 (0.307%) 2.61±0.41 (0.261%)
Ascorbic acid 5.87±0.38 (0.587%) 3.98±0.38 (0.398%) 3.29±0.34 (0.329%)
FRAP value mmole/gm 0.045±0.003 0.04±0.002 0.031±0.003
Table 3: Eﬀect of feeding diﬀerent combinations on hepatic lipid proﬁles, HMG-CoA reductase activity and bile acid content (mg/gm).
Group NC HC C-I C-II C-III
Total lipids 30±2.9d 126.8±4.3a (+322.76) 91.7±3.1bc (−27.72) 83.8±3.2c (−33.90) 101.3±3.1b (−20.10)
Total cholesterol 1.9±0.1d 36.1±1.7a (+1769.43) 24.9±1.5bc (−30.90) 23.5±1.3bc (−34.75) 29±1.4b (−19.53)
Triglycerides 3 ±0.1b 24.3±1.4a (+705.96) 20.2±1.2a (−17.00) 22.1±1.7a (−9.20) 22.3±1.8a (−8.50)
HMG CoA reductase∗ 2.8±0.1e 7.1±0.1a (−156.67) 6±0.1bc (+15.75) 5.8±0.1cd (+18.84) 6.2±0.1b (+12.93)
Bile acid 3.8±0.1d 6.9±0.1c (+83.55) 8.8±0.1a (+27.45) 9.2±0.1a (+33.09) 8±0.1b (+16.18)
Values: mean ± SEM (n = 6).
Figures in parentheses indicate percent increase (+) or decrease (−).
Within a row those with diﬀerent superscripts are signiﬁcantly diﬀerent (P < 0.002).
∗HMG-CoA reductase activity is inversely proportional to the ratio of HMG-CoA/mevalonate (absorbance of HMG-CoA/absorbance of mevalonate), that
is, the increase in ratio corresponds to a decrease in enzyme activity.
Comparisons for the percentage were made between groups NC and HC; HC and C-I; HC and C-II; HC and C-III.
on commercial feed (Pranav Agro Ind. Ltd., Pune, India) in
a well-ventilated animal unit (26± 2◦C, humidity 56%, 12
hour-light/dark cycle). The care and procedures adopted for
the present investigation were in accordance with rules and
regulations of CPCSEA, and the experiment was approved
by Institutional Animal Ethics Committee (IAEC).
4.3. Experimental Design. After a 10-day adaptation period,
30 rats were divided into 5 groups of 6 rats each: NC: normal
control rats receiving only commercial feed/ basal diet, HC:
high cholesterol diet control rats receiving basal diet with
0.5gm% cholesterol and 1.0gm% sodium taurocholate, C-
I: rats receiving high cholesterol diet+combination I, C-II:
rats receiving high cholesterol diet+combination II, and C-
III:ratsreceivinghighcholesteroldiet+combinationIII.The
basal diet contained 55.67gm% carbohydrates, 22.12gm%
protein, 4.06gm% fat, 3.76gm% ﬁber, 5.64gm% mineral
mixture, and 8.75% moisture content.
At the end of the four-week treatment, 24-hour fecal
samples were collected from individual cages. Animals
were fasted overnight and sacriﬁced under mild anesthesia
(diethyl ether). Blood was collected by cardiac puncture, and
plasma was separated by centrifugation. Liver was excised,
and, both plasma and liver were kept frozen until analyzed.
4.4. Plasma and Hepatic Lipid Proﬁles. Plasma total lipid
(TL) content was estimated by sulpho-phosphovanillin
method [46]. Plasma cholesterol (TC), HDL-cholesterol
(HDL-C), and triglycerides (TG) were assayed using com-
mercial diagnostic kits (Eve’s Inn Diagnostics, Vadodara,
India). Low-density lipoprotein cholesterol (LDL-C), very-
low-density lipoprotein cholesterol (VLDL-C), and athero-
genic index (AI) were calculated according to Friedewald
equations [47]. The liver TL was extracted in chloro-
form:methanol (2:1) [48] and estimated gravimetrically.
Hepatic TC and TG were extracted [48] and estimated using
the standard kits (Eve’s Inn Diagnostics, Vadodara, India).
4.5. Hepatic HMG-CoA Reductase and Bile Acid Proﬁle.
Hepatic HMG-CoA reductase (EC 1.1.1.34) activity was
measured in terms of the ratio of HMG-CoA to mevalonate
using hydroxylamine-FeCl3 reagent [49]. Brieﬂy, the hepatic
HMG-CoA was determined by its reaction with hydroxy-
lamine reagent at alkaline pH and followed by colorimetric
measurement of the resulting hydroxamic acid by formation
of complexes with ferric salts at 540nm. The hepatic
mevalonate was estimated by reaction with the same reagent
but at pH 2.1. At this pH, the lactone form of mevalonate
readily reacts with hydroxylamine to form the hydroxamate.
Thus, hepatic HMG-CoA and mevalonate concentration in
thetissuehomogenateareestimatedintermsofabsorbances,
and the ratio between the two is taken as an index of
the HMG-CoA reductase enzyme activity that catalyzes
the conversion of 3-hydroxy-3-methylglutaryl-coenzyme A
to mevalonate. The ratio is inversely proportional to the
enzyme activity, that is, the increase in ratio corresponds to
a decrease in enzyme activity. The alkaline-ethanol extract of
hepatic bile acid was acidiﬁed and estimated using vanillin-
phosphoric acid reagent [50].
4.6. Fecal Cholesterol, Neutral Sterol, and Bile Acid Content.
The fecal cholesterol, neutral sterol, and bile acid were6 Oxidative Medicine and Cellular Longevity
Table 4: Eﬀect of feeding diﬀerent combinations on fecal cholesterol, neutral sterols, and bile acid excretion (mg/gm).
Group NC HC C-I C-II C-III
Cholesterol 1.9±0.1d 6.1±0.2c (+208.08) 7±0.1ab (+15.24) 7.2±0.1ab (+18.85) 6.8±0.2bc (+10.98)
Neutral sterols 4.9±0.2d 8.2±0.2c (+66.26) 9.8±0.1ab (+19.19) 10.1±0.2a (+23.08) 9.2±0.2b (+12.39)
Bile acid 5.7±0.2c 11±0.4b (+94.34) 14.2±0.5a (+29.18) 14.7±0.3a (+33.90) 13±0.3a (+18.36)
Values: mean ± SEM (n = 6).
Figures in parentheses indicate percent increase (+) or decrease (−).
Within a row those with diﬀerent superscripts are signiﬁcantly diﬀerent (P < 0.002).
Comparisons for the percentage were made between groups NC and HC; HC and C-I; HC and C-II; HC and C-III.
extracted using alkaline methanol medium [51], and fecal
c h o l e s t e r o la n dn e u t r a ls t e r o lc o n t e n t sw e r ee s t i m a t e d[ 52]
using standard kits (Eve’s Inn Diagnostics, Vadodara, India).
A portion of the extract was acidiﬁed and used for bile acid
estimation [50].
4.7. Hepatic Lipid Peroxidation and Antioxidant Proﬁle. The
concentration of the lipid peroxide products of hepatic
TBARS (Thiobarbituric acid reactive substances) was mea-
sured by TBA-TCA-HCl reagent (0.37% TBA, 15% TCA,
0.25 N HCl) at 532nm using a molar absorption coeﬃcient
of 1.56×105 M−1cm−1 [53]. Catalase (EC 1.11.1.6) activity
was measured spectrophotometrically as decomposition of
H2O2 at 240nm [54]. The superoxide dismutase (SOD; EC
1.15.1.1) was assayed by using NADPH and PMS (phenazine
methosulfate) reagents under nonacidic conditions, which
reduces NBT (nitroblue tetrazolium salt) and forms a blue
coloured formazon that can be measured at 560nm [55].
Total ascorbic acid was determined using 2,4-dinitro phenyl
hydrazine (DNPH) H2SO4 reagent [44]. The FRAP value of
plasma was measured by the method of Benzie and Strain
[45].
4.8. Statistical Evaluation. Results are expressed as means ±
SEM. Signiﬁcant diﬀerences among the groups were deter-
mined by one-way ANOVA using the 10th version of SPSS
with Duncan’s test as post hoc analysis. Diﬀerences were
considered signiﬁcant if P < 0.002.
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